本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aurinia Pharmaceuticals Inc

15.83
-0.2200-1.37%
盘前15.870.0373+0.24%07:00 EDT
成交量:84.62万
成交额:1,341.77万
市值:21.05亿
市盈率:7.65
高:16.03
开:15.97
低:15.71
收:16.05
52周最高:16.54
52周最低:7.29
股本:1.33亿
流通股本:1.28亿
量比:0.85
换手率:0.66%
股息:- -
股息率:- -
每股收益(TTM):2.07
每股收益(LYR):2.07
净资产收益率:59.91%
总资产收益率:11.16%
市净率:3.62
市盈率(LYR):7.65

数据加载中...

2019/07/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/04

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/05/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/18

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/11/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]